During his time in academia, Andrew originally studied biological sciences in Cardiff, specializing in respiratory physics. In 1991, Andrew joined Glaxo Group Research, formulating and analyzing inhaled medicines. Andrew went on to specialize in the physical analysis of raw materials and products, expanding into oral and other formulation types. During his 24 years with Glaxo, Glaxo Wellcome and GlaxoSmithKline, he took on roles of increasing responsibility, ultimately managing a materials science group and representing GSK in various academic collaborations. Three years ago, Andrew moved to Spain and joined Chemo R&D in Madrid. As R&D Manager - Physical Properties, he is responsible for defining the physical characteristics of API, excipients and formulated materials, across a broad portfolio, to ensure consistent product performance.
展开▼
